Dr. Zalak Patel assumed the role of Instructor in Medicine in the Division of Hospital Medicine in July 2024. Originally from Ahmedabad, India, she earned her medical degree from Gujarat University in 2019 after attending Smt. N.H.L. Municipal Medical College, Ahmedabad. After graduating, she served as a medical officer in various Indian hospitals, focusing on providing healthcare to the less privileged population of India. During her time in India, Dr. Patel also volunteered at the Blind People Association, where she played a significant role in creating audiobooks for visually impaired physiotherapy students. Dr. Patel relocated to the USA in 2021 and completed her internship and residency at the University of California, Riverside School of Medicine, St. Bernardine Medical Center, CA, before joining the hospital medicine division at Washington University in 2024. Throughout her training, she demonstrated a wide range of interests and actively participated in numerous research projects and quality improvement initiatives.
Education
- Medical Degree: Smt NHL Municipal Medical College, Ahmedabad, Gujarat (2019)
- Residency, Internal Medicine: University of California, Riverside School of Medicine, St. Bernardine Medical Center, CA (2024)
Clinical Interests
Internal medicine, inpatient care, rheumatology
Publications
A Nationwide Retrospective Analysis: Examining the Influence of Frailty on Patients with Bladder Cancer. 2023 ASCO Quality Care Symposium. Pub Status: Accepted
Efficacy and Safety of Pembrolizumab in Advanced Neuroendocrine Tumors (NETs): A Meta-Analysis of Clinical Trials. 2023 ASCO Breakthrough. Pub Status: Published
Efficacy of Fibroblast Growth Factor Receptor (FGFR) Inhibitors Therapy in Advanced Cholangiocarcinoma with FGFR Genes Alterations: A Meta-Analysis of Phase II Clinical Trials. 2023 ASCO Breakthrough. Pub Status: Published
Palliative Care, Healthcare Utilization, and Disparities in Deceased Breast Cancer Patients in U.S. Hospitals: Analysis of National Inpatient Sample. San Antonio Breast Cancer Symposium 2023. Pub Status: Under Review
Disparities in Palliative Care Utilization in Deceased Lymphoma Patients. ASH 2023 (65th Annual Meeting). Pub Status: Under Review
Age-Specific Outcomes in Breast Cancer Patients Treated with Aromatase Inhibitors -A National Inpatient Sample Database Analysis. San Antonio Breast Cancer Symposium 2023. Pub Status: Under Review
Conquering complex congenital cardiac complications: A tale of covid-19, pulmonary embolism, and valve thrombus in a tetralogy of fallot patient. CHEST. Pub Status: Accepted
Efficacy of PARP inhibitors in patients with metastatic castration resistant prostate carcinoma: A meta-analysis of phase III randomized controlled trials. Journal of Clinical Oncology. Pub
Status: Published
CPAP machine non-compliance secondary to the facial rash caused by 30 years of neoprene sensitization. CHEST. Pub Status: Accepted
Immune checkpoint inhibitors therapy in advanced bladder carcinoma: A meta-analysis of phase III randomized controlled trials. Journal of Clinical Oncology. Pub Status: Published